These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 35806183)

  • 61. Clinical Evaluation of Cerebrospinal Fluid p217tau and Neurofilament Light Chain Levels in Patients with Alzheimer's Disease or Other Neurological Diseases.
    Kawarabayashi T; Nakamura T; Miyashita K; Segawa T; Fukamachi I; Sugawara T; Oka H; Ishizawa K; Amari M; Kasahara H; Makioka K; Ikeda Y; Takatama M; Shoji M
    J Alzheimers Dis; 2023; 96(4):1623-1638. PubMed ID: 38007650
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Neurofilament light chain as a biomarker in neurological disorders.
    Gaetani L; Blennow K; Calabresi P; Di Filippo M; Parnetti L; Zetterberg H
    J Neurol Neurosurg Psychiatry; 2019 Aug; 90(8):870-881. PubMed ID: 30967444
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Correlation between cerebrospinal fluid and plasma neurofilament light protein in treated HIV infection: results from the COBRA study.
    Alagaratnam J; De Francesco D; Zetterberg H; Heslegrave A; Toombs J; Kootstra NA; Underwood J; Gisslen M; Reiss P; Fidler S; Sabin CA; Winston A
    J Neurovirol; 2022 Feb; 28(1):54-63. PubMed ID: 34874540
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Abnormal prion protein, infectivity and neurofilament light-chain in blood of macaques with experimental variant Creutzfeldt-Jakob disease.
    Yakovleva O; Bett C; Pilant T; Asher DM; Gregori L
    J Gen Virol; 2022 Jul; 103(7):. PubMed ID: 35816369
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Blood and cerebrospinal fluid neurofilament light differentially detect neurodegeneration in early Alzheimer's disease.
    Andersson E; Janelidze S; Lampinen B; Nilsson M; Leuzy A; Stomrud E; Blennow K; Zetterberg H; Hansson O
    Neurobiol Aging; 2020 Nov; 95():143-153. PubMed ID: 32810755
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Neurofilament changes in serum and cerebrospinal fluid after acute ischemic stroke.
    Pujol-Calderón F; Portelius E; Zetterberg H; Blennow K; Rosengren LE; Höglund K
    Neurosci Lett; 2019 Apr; 698():58-63. PubMed ID: 30599262
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Relationships between clinicopathological features and cerebrospinal fluid biomarkers in Japanese patients with genetic prion diseases.
    Higuma M; Sanjo N; Satoh K; Shiga Y; Sakai K; Nozaki I; Hamaguchi T; Nakamura Y; Kitamoto T; Shirabe S; Murayama S; Yamada M; Tateishi J; Mizusawa H
    PLoS One; 2013; 8(3):e60003. PubMed ID: 23555862
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Neurofilament light chain in the assessment of patients with multiple sclerosis.
    Domingues RB; Fernandes GBP; Leite FBVM; Senne C
    Arq Neuropsiquiatr; 2019 Jul; 77(6):436-441. PubMed ID: 31314847
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Neurofilaments in Sporadic and Familial Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis.
    Shahim P; Norato G; Sinaii N; Zetterberg H; Blennow K; Chan L; Grunseich C
    Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674431
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Association of Cerebrospinal Fluid Neurofilament Light Concentration With Alzheimer Disease Progression.
    Zetterberg H; Skillbäck T; Mattsson N; Trojanowski JQ; Portelius E; Shaw LM; Weiner MW; Blennow K;
    JAMA Neurol; 2016 Jan; 73(1):60-7. PubMed ID: 26524180
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Cerebrospinal fluid biomarkers in the Longitudinal Early-onset Alzheimer's Disease Study.
    Dage JL; Eloyan A; Thangarajah M; Hammers DB; Fagan AM; Gray JD; Schindler SE; Snoddy C; Nudelman KNH; Faber KM; Foroud T; Aisen P; Griffin P; Grinberg LT; Iaccarino L; Kirby K; Kramer J; Koeppe R; Kukull WA; La Joie R; Mundada NS; Murray ME; Rumbaugh M; Soleimani-Meigooni DN; Toga AW; Touroutoglou A; Vemuri P; Atri A; Beckett LA; Day GS; Graff-Radford NR; Duara R; Honig LS; Jones DT; Masdeu JC; Mendez MF; Musiek E; Onyike CU; Riddle M; Rogalski E; Salloway S; Sha SJ; Turner RS; Wingo TS; Wolk DA; Womack KB; Carrillo MC; Dickerson BC; Rabinovici GD; Apostolova LG;
    Alzheimers Dement; 2023 Nov; 19 Suppl 9(Suppl 9):S115-S125. PubMed ID: 37491668
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Evaluation of a preclinical blood test for scrapie in sheep using immunocapillary electrophoresis.
    Jackman R; Everest DJ; Schmerr MJ; Khawaja M; Keep P; Docherty J
    J AOAC Int; 2006; 89(3):720-7. PubMed ID: 16792071
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Dimethyl fumarate decreases neurofilament light chain in CSF and blood of treatment naïve relapsing MS patients.
    Sejbaek T; Nielsen HH; Penner N; Plavina T; Mendoza JP; Martin NA; Elkjaer ML; Ravnborg MH; Illes Z
    J Neurol Neurosurg Psychiatry; 2019 Dec; 90(12):1324-1330. PubMed ID: 31611264
    [TBL] [Abstract][Full Text] [Related]  

  • 74. CSF biomarkers of neuroinflammation in distinct forms and subtypes of neurodegenerative dementia.
    Abu-Rumeileh S; Steinacker P; Polischi B; Mammana A; Bartoletti-Stella A; Oeckl P; Baiardi S; Zenesini C; Huss A; Cortelli P; Capellari S; Otto M; Parchi P
    Alzheimers Res Ther; 2019 Dec; 12(1):2. PubMed ID: 31892365
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Elevated manganese levels in blood and central nervous system occur before onset of clinical signs in scrapie and bovine spongiform encephalopathy.
    Hesketh S; Sassoon J; Knight R; Hopkins J; Brown DR
    J Anim Sci; 2007 Jun; 85(6):1596-609. PubMed ID: 17296770
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Neurofilament light chain: A possible fluid biomarker in the intrahippocampal kainic acid mouse model for chronic epilepsy?
    Custers ML; Vande Vyver M; Kaltenböck L; Barbé K; Bjerke M; Van Eeckhaut A; Smolders I
    Epilepsia; 2023 Aug; 64(8):2200-2211. PubMed ID: 37264788
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Associations of Neurodegeneration Biomarkers in Cerebrospinal Fluid with Markers of Alzheimer's Disease and Vascular Pathology.
    Shir D; Mielke MM; Hofrenning EI; Lesnick TG; Knopman DS; Petersen RC; Jack CR; Algeciras-Schimnich A; Vemuri P; Graff-Radford J
    J Alzheimers Dis; 2023; 92(3):887-898. PubMed ID: 36806507
    [TBL] [Abstract][Full Text] [Related]  

  • 78. CSF-Neurofilament Light Chain Levels in NMDAR and LGI1 Encephalitis: A National Cohort Study.
    Nissen MS; Ryding M; Nilsson AC; Madsen JS; Olsen DA; Halekoh U; Lydolph M; Illes Z; Blaabjerg M
    Front Immunol; 2021; 12():719432. PubMed ID: 34975832
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Elevated cerebrospinal fluid neurofilament light levels in patients with amyotrophic lateral sclerosis: a possible marker of disease severity and progression.
    Tortelli R; Ruggieri M; Cortese R; D'Errico E; Capozzo R; Leo A; Mastrapasqua M; Zoccolella S; Leante R; Livrea P; Logroscino G; Simone IL
    Eur J Neurol; 2012 Dec; 19(12):1561-7. PubMed ID: 22680408
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Validation of Plasma and CSF Neurofilament Light Chain as an Early Marker for Sporadic Creutzfeldt-Jakob Disease.
    Schmitz M; Canaslan S; Espinosa JC; Fernández-Borges N; Villar-Piqué A; Llorens F; Varges D; Maass F; Torres JM; Hermann P; Zerr I
    Mol Neurobiol; 2022 Sep; 59(9):1-9. PubMed ID: 35716271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.